日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytomegalovirus reactivation prevention and treatment post-hematopoietic stem cell transplantation: a Delphi study in four Gulf cooperation council countries

造血干细胞移植后巨细胞病毒再激活的预防和治疗:海湾合作委员会四个国家的德尔菲研究

Prats, João Antonio Goncalves Garreta; Farsi, Khalil Al; Al-Khabori, Murtadha; Al-Saadawi, Nameer; Alshemmari, Salem H; Cherif, Honar; Ibrahim, Dima; Kaloyannidis, Panayotis; Swaka, Robert Lodu Serafino Wani

AntiCD30-Conjugated Antibody Plus Standard BEAM as Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Systemic Anaplastic Large Cell Lymphoma

抗CD30偶联抗体联合标准BEAM方案作为系统性间变性大细胞淋巴瘤自体造血干细胞移植的预处理方案

Kaloyannidis, Panayotis; Al-Charfli, Basmah; George, Biju; Khalil, Charbel; Al-Moghrabi, Nour; Mustafa, Samar; Ibrahim, Dima; Alfar, Mohammed; Ibrahim, Firuz; Odeh, Bassam; Daryahya, Mohammed; Shabo, Philip

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

在新型治疗方式时代,对新确诊的健康年轻多发性骨髓瘤患者进行风险评估:是否应考虑其他因素?

Kaloyannidis, Panayotis; Abdulla, Fatema; Mutahar, Enas; Al Hashim, Haidar; Al Harbi, Salman; Estanislao, Analie; Al Hashmi, Hani

Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge

阿联酋首个综合成人及儿童造血干细胞移植中心成立:迎接挑战

Humaid O Al-Shamsi, Amin Abyad, Panayotis Kaloyannidis, Amro El-Saddik, Ahmad Alrustamani, Ibrahim Abu Gheida, Azzam Ziade, Norbert W Dreier, Urfan Ul-Haq, Thanda Lucy Ann Joshua, Abdul Rahman El Kinge, Ritika Coelho, Dima Ibrahim, Mehdi Afrit, Bilal Al-Lababidi, Zainul Aabideen, Mayur Sabhani, Rake

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East

中东地区关于造血干细胞移植患者 COVID-19 的临床过程和结局报告

El Fakih, Riad; Haroon, Alfadil; Alfraih, Feras; Al-Khabori, Murtadha K; Alzahrani, Mohsen; Alhuraiji, Ahmad; Hamadah, Abdulaziz; AlJohani, Naif I; Alahmari, Bader; Essa, Mohammed F; Motabi, Ibraheem H; Tailor, Imran K; Almaghrabi, Reem S; Al-Farsi, Khalil; Abosoudah, Ibraheem; Ayas, Mouhab; Elhassan, Tusneem A; Suhebeh, Ashraf M; Ahmed, Syed Osman; Alhayli, Saud; Kaloyannidis, Panayotis; Alsaeed, Ahmad; Anezi, Khalid Al; Alamoudi, Sameer; Damlaj, Moussab; Hashmi, Hani Al; Aljurf, Mahmoud

Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

对于移植后复发的难治性霍奇金淋巴瘤,采用递增剂量纳武利尤单抗进行重复治疗:一种安全有效的治疗方法

Kaloyannidis, Panayotis; Al Shaibani, Eshrak; Moinnudin, Asif; Al Anezi, Khalid; Al Hashmi, Hani

Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration

建立造血干细胞移植项目;通过合作克服成本问题

Al-Hashmi, Hani; Alsagheir, Ahmed; Estanislao, Analie; Bacal, Jenifer; Alsuhebah, Ashraf; Alblowe, Belal; Raslan, Heba; Alsaber, Arwa; Albahrani, Ahmed; Almulhem, Norah; Alamri, Amal; Alsaleh, Khalid; Albeihany, Amal; Alabdulwahab, Amal; Bakkar, Mohammed; Kaloyannidis, Panayotis

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation

Brentuximab vedotin 用于治疗自体干细胞移植后复发或难治性霍奇金淋巴瘤患者

Kaloyannidis, Panayotis; Hertzberg, Mark; Webb, Kate; Zomas, Athanasios; Schrover, Rudolf; Hurst, Michael; Jacob, Ian; Nikoglou, Thalia; Connors, Joseph M

Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma

免疫检查点抑制剂在非霍奇金淋巴瘤中的当前临床应用及未来展望

Apostolidis, John; Sayyed, Ayman; Darweesh, Mohammed; Kaloyannidis, Panayotis; Al Hashmi, Hani

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

硼替佐米联合鲁索替尼治疗类固醇难治性慢性移植物抗宿主病

Kaloyannidis, Panayotis; Shaibani, Eshrak Al; Apostolidis, Ioannis; Kanfar, Solaf; Anezi, Khalid Al; Hashmi, Hani Al